These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19179470)

  • 21. Dehydroepiandrosterone inhibits the TNF-alpha-induced inflammatory response in human umbilical vein endothelial cells.
    Gutiérrez G; Mendoza C; Zapata E; Montiel A; Reyes E; Montaño LF; López-Marure R
    Atherosclerosis; 2007 Jan; 190(1):90-9. PubMed ID: 16574124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum-resistant strains of Borrelia burgdorferi evade complement-mediated killing by expressing a CD59-like complement inhibitory molecule.
    Pausa M; Pellis V; Cinco M; Giulianini PG; Presani G; Perticarari S; Murgia R; Tedesco F
    J Immunol; 2003 Mar; 170(6):3214-22. PubMed ID: 12626580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by C5b-9 does not involve increased C7 binding or cell-bound C3b.
    Rosenfeld SI; Jenkins DE; Leddy JP
    J Immunol; 1985 Jan; 134(1):506-11. PubMed ID: 3964820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The membrane attack complex of complement alters the membrane integrity of cultured endothelial cells: a possible pathophysiology for immune complex vasculitis.
    Kawana S
    Acta Derm Venereol; 1996 Jan; 76(1):13-6. PubMed ID: 8721482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular organization of C9 within the membrane attack complex of complement. Induction of circular C9 polymerization by the C5b-8 assembly.
    Podack ER; Tschoop J; Müller-Eberhard HJ
    J Exp Med; 1982 Jul; 156(1):268-82. PubMed ID: 6177822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL-4 and IL-13 induce protection from complement and melittin in endothelial cells despite initial loss of cytoplasmic proteins: membrane resealing impairs quantifying cytotoxicity with the lactate dehydrogenase permeability assay.
    Benson BA; Vercellotti GM; Dalmasso AP
    Xenotransplantation; 2015; 22(4):295-301. PubMed ID: 26031609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of terminal complement complex formation and cell lysis by monoclonal antibodies.
    Würzner R; Schulze M; Happe L; Franzke A; Bieber FA; Oppermann M; Götze O
    Complement Inflamm; 1991; 8(5-6):328-40. PubMed ID: 1724954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The membrane attack complex of complement induces interleukin-8 and monocyte chemoattractant protein-1 secretion from human umbilical vein endothelial cells.
    Kilgore KS; Flory CM; Miller BF; Evans VM; Warren JS
    Am J Pathol; 1996 Sep; 149(3):953-61. PubMed ID: 8780399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional identification of serum complement components following electrophoresis in polyacrylamide gels containing sodium dodecyl sulphate.
    Orren A; Lerch WH; Dowdle EB
    J Immunol Methods; 1983 Apr; 59(1):63-71. PubMed ID: 6833775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Membrane attack complex proteins C5b-6, C7, C8, and C9 of human complement.
    Esser AF; Sodetz JM
    Methods Enzymol; 1988; 162():551-78. PubMed ID: 3226325
    [No Abstract]   [Full Text] [Related]  

  • 31. Clusterin and the terminal complement pathway synthesized by human umbilical vein endothelial cells are closely linked when detected on co-cultured agarose beads.
    Berge V; Johnson E; Høgåsen K
    APMIS; 1997 Jan; 105(1):17-24. PubMed ID: 9063496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vitronectin modulates the expression of complement components of the terminal pathway synthesized by human umbilical vein endothelial cells in vitro.
    Berge V; Berge KE; Johnson E
    APMIS; 1996; 104(7-8):523-30. PubMed ID: 8920805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human serum-induced expression of E-selectin on porcine aortic endothelial cells in vitro is totally complement mediated.
    Sølvik UØ; Haraldsen G; Fiane AE; Boretti E; Lambris JD; Fung M; Thorsby E; Mollnes TE
    Transplantation; 2001 Dec; 72(12):1967-73. PubMed ID: 11773897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Streptococcal inhibitor of complement (SIC) inhibits the membrane attack complex by preventing uptake of C567 onto cell membranes.
    Fernie-King BA; Seilly DJ; Willers C; Würzner R; Davies A; Lachmann PJ
    Immunology; 2001 Jul; 103(3):390-8. PubMed ID: 11454069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complement factor 7 gene mutations in relation to meningococcal infection and clinical recurrence of meningococcal disease.
    Kuijpers TW; Nguyen M; Hopman CT; Nieuwenhuys E; Dewald G; Lankester AC; Roos A; van der Ende A; Fijen C; de Boer M
    Mol Immunol; 2010 Jan; 47(4):671-7. PubMed ID: 19931914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerivastatin reduces cytokine-induced surface expression of ICAM-1 via increased shedding in human endothelial cells.
    Landsberger M; Wolff B; Jantzen F; Rosenstengel C; Vogelgesang D; Staudt A; Dahm JB; Felix SB
    Atherosclerosis; 2007 Jan; 190(1):43-52. PubMed ID: 16529752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of mRNA for the terminal complement components C5, C6, C8 and C9 in human umbilical vein endothelial cells in vitro.
    Langeggen H; Berge KE; Macor P; Fischetti F; Tedesco F; Hetland G; Berg K; Johnson E
    APMIS; 2001 Jan; 109(1):73-8. PubMed ID: 11297196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cross-talk between the complement system and endothelial cells in physiologic conditions and in vascular diseases.
    Fischetti F; Tedesco F
    Autoimmunity; 2006 Aug; 39(5):417-28. PubMed ID: 16923542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [C7 deficiency].
    Hara T
    Ryoikibetsu Shokogun Shirizu; 2000; (32):208-9. PubMed ID: 11212692
    [No Abstract]   [Full Text] [Related]  

  • 40. SC5b-7, SC5b-8 and SC5b-9 complexes of complement: ultrastructure and localization of the S-protein (vitronectin) within the macromolecules.
    Preissner KP; Podack ER; Müller-Eberhard HJ
    Eur J Immunol; 1989 Jan; 19(1):69-75. PubMed ID: 2465906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.